A modified regimen of low-dose rituximab therapy for patients with refractory immune thrombocytopenia associated with systemic lupus erythematosus

• Hauptverfasser: Shuo Zhang (Verfasst von), Nan Jiang (Verfasst von), Li Wang (Verfasst von), Li Zhang (Verfasst von), Hua Chen (Verfasst von), Mengtao Li (Verfasst von), Xiaofeng Zeng (Verfasst von)
• Format: Buch
• Veröffentlicht: SAGE Publishing, 2021-10-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Background: Severe and refractory immune thrombocytopenia (ITP) affects the life expectancy of patients with systemic lupus erythematosus (SLE) and poses a challenge in their clinical management. This intervention study employed a small sample size to evaluate the efficacy and safety of a modified l...